Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
innohep®
DRUG
2 trials
Sponsors
LEO Pharma
Conditions
Deep Vein Thrombosis
Venous Thromboembolism
Phase 3
Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer
Completed
NCT01130025
LEO Pharma
Venous Thromboembolism
Start: 2010-08-31
End: 2014-05-31
Updated: 2025-02-24
Phase 4
Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis
Completed
NCT00277394
LEO Pharma
Deep Vein Thrombosis
Start: 2005-12-31
End: 2008-07-31
Updated: 2025-03-06
Related Papers
Efficacy and Safety Outcomes in Patients with Cancer-Associated Thromboembolism Treated with Tinzaparin According to the Tumor Site: Meta-Analysis of Prospective Studies Involving 1413 Individual Patients' Data
Blood
2023-11-02
3 citations
Efficacy and Safety of Tinzaparin in CAT Patients with Hematological Malignancy
Blood
2021-11-05
Efficacy and Safety of Tinzaparin in CAT Patients with Metastatic Disease
Blood
2020-11-04
Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study.
2018-04-17
25 citations
Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism-Analysis of the CATCH Study.
2018-04-04
35 citations
Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer
JAMA
2015-08-18
603 citations
Clinical predictors of recurrent venous thromboembolism (VTE) in cancer patients from a randomized trial of long-term tinzaparin versus warfarin for treatment: The CATCH study.
Journal of Clinical Oncology
2015-05-20
14 citations
A Randomized Trial of Long-Term Tinzaparin, a Low Molecular Weight Heparin (LMWH), Versus Warfarin for Treatment of Acute Venous Thromboembolism (VTE) in Cancer Patients - the CATCH Study
Blood
2014-12-06
26 citations
CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients.
2013-06-13
52 citations